Cargando…
Identification of High Death Risk Coronavirus Disease-19 Patients using Blood Tests
BACKGROUND: The coronavirus disease (COVID-19) pandemic has made a great impact on health-care services. The prognosis of the severity of the disease help reduces mortality by prioritizing the allocation of hospital resources. Early mortality prediction of this disease through paramount biomarkers i...
Autores principales: | Zadeh Hosseingholi, Elaheh, Maddahi, Saeede, Jabbari, Sajjad, Molavi, Ghader |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482375/ https://www.ncbi.nlm.nih.gov/pubmed/36124024 http://dx.doi.org/10.4103/abr.abr_178_21 |
Ejemplares similares
-
Rational design of an anti-cancer peptide inhibiting CD147 / Cyp A interaction
por: Maani, Zahra, et al.
Publicado: (2023) -
The effect of interferon in the therapy of severe coronavirus infection
por: Shajari, Rasoul, et al.
Publicado: (2023) -
Bioactivity of Malva Sylvestris L., a Medicinal Plant from Iran
por: Razavi, Seyed Mehdi, et al.
Publicado: (2011) -
Comparison between Brush Cytology and Forceps Biopsy under Fluoroscopic Guidance for the Diagnosis of Proximal Cholangiocarcinoma
por: Hormati, Ahmad, et al.
Publicado: (2020) -
Change Paradigm in the Face of COVID-19; From Bans to Incentives
por: Jabbari, Alireza, et al.
Publicado: (2021)